Wells Fargo Reduces PT on Danaher Corporation (DHR) to $205; Maintains ‘Equal Weight’ Rating

With a year-to-date decline in share price, along with strong hedge fund interest, Danaher Corporation (NYSE:DHR) secures a place on our list of the 11 Best Rebound Stocks to Buy According to Hedge Funds.

Wells Fargo Reduces PT on Danaher Corporation (DHR) to $205; Maintains ‘Equal Weight’ Rating

A laboratory technician researching a sample of cells in a biotechnology laboratory.

On July 23, 2025, Wells Fargo reduced its price target on Danaher Corporation (NYSE:DHR) from $210 to $205, maintaining an ‘Equal Weight’ rating. This price revision follows the company’s quarterly results. DHR delivered a solid EPS beat and upward guidance revision during the quarter. Furthermore, the investment firm noted that the company held an additional $0.15-$0.20 per share in reserve.

Expectations for a robust recovery stemming from ongoing strength in the company’s Bioprocess segment further fueled the analyst’s optimism. Additionally, the Life Science segment is expected to record improvement in the second half of the year. At the same time, positive trends in the Pharma segment and growing momentum in China are driving analyst sentiment.

Danaher Corporation (NYSE:DHR) offers professional, medical, research, and industrial products and services with its Biotechnology, Life Sciences, and Diagnostics segments. It is included in our list of the Best Rebound Stocks To Buy.

While we acknowledge the potential of DHR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DHR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks.

Disclosure: None.